Exec. Director, Therapeutic Area Strategy, Cardiovascular

Your responsibilities include, but not limited to:  
    Develop Strategy for a Cardio Renal or Metabolic portfolio pillar and contribute to overall TA strategy 
    Define and drive mid-and-long term portfolio strategy, goals, strategic objectives and leadership aspiration within TA and DAs in collaboration with other functions within Strategy & Growth (S&G), and across US and International commercial, Biomedical Research, and Development units
    Support the Therapeutic Area Leadership team (TAL) as the Enterprise strategic body that owns the TA Strategy and reviews all programs at Toll Gate transitions (from drug candidate to SDP) 
    Lead strategy revisions and updates and orchestrate stakeholder alignment as needed, e.g., due to internal or external market events.
    Identify potential pipeline gaps and make recommendations to address with other S&G functions, US, International, Biomedical Research, and Development
    Commercial lead on external evaluations for BD&L and acquisitions, inception to deal close.  Developing evaluations (across all phase products) based a thorough understanding of the TA, insights developed and tested externally using secondary analytics, PMR and CI. 
    Commercial lead on the early phase project teams (from drug candidate to Phase 3). Responsible for p3 programs transition to US and International Markets,
    Responsible for forecast and other commercial models’ development and alignment with key markets 
    Collaborate closely with key stakeholders (e.g., US, International, Biomedical Research, Development, and engage other functions such as Value & Access and US Market Access) to facilitate port-folio decision making in the context of our goal of becoming a top 5 Pharma player in the US while maintaining our international leadership.

Key Requirements:

• Advanced degree (PhD, MD cardiologist or internal medicine preferred) or equivalent experience in life science/healthcare; MBA.
• Significant experience gained in Pharma Industry with a strong Scientific or medical background
• Significant BD&L and or M&A deal and evaluation experience (agile in assimilating technical and medical data, financial modelling (forecasting, P&L), conducting, commissioning, analyzing primary and secondary research)
• Demonstrated Consulting experience & C-suite presentation skills, written and oral
• Demonstrated Therapeutic Area (TA) knowledge and experience in Cardio Renal or Metabolic (or track record to acquire required TA expertise effectively and rapidly)
• Experience of strategy development and asset shaping early in lifecycle.
• Highly agile having the capacity to manage several strategic Disease Areas (Das) within a TA and multiple programs internal and external.
• Highly analytical with the ability to lead and thrive in high challenging environment.
• Proficiency in English required. (spoken and written).
• Extensive US market experience
• Effective and persuasive communicator with strong presentation, communication (both written and verbal), influencing and negotiation skills.
• Travel: ability to travel domestically and internationally, to be determined based on business needs